Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma
Abdul Wali Khan, Collin W. English, William Chen, Prazwal Athukuri, James C. Bayley, Vicky Brandt, Arya Shetty, Caroline Hadley, Abrar Choudhury, Hsiang‐Chih Lu, Arif Harmanci, Akdes Serin Harmancı, Stephen T. Magill, David R. Raleigh, Tiemo J. Klisch, Akash J. Patel
Topics & Concepts
CDKN2AMeningiomaMedicineInternal medicineSurgeryCancerMeningioma and schwannoma managementGlioma Diagnosis and TreatmentNeurofibromatosis and Schwannoma Cases